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ABSTRACT
We investigated the eVects of polyamine bio-
synthesis inhibition on the estrogenic signaling
pathway of MCF-7 breast cancer cells using a
protein–protein interaction system. Estrogen
receptor (ER) linked to glutathione-S-transferase
(GST) was used to examine the eVects of two
polyamine biosynthesis inhibitors, diﬂuoro-
methylornithine (DFMO) and CGP 48664. ER was
speciﬁcally associated with a 45 kDa protein in
control cells. In cells treated with estradiol, nine
proteins were associated with ER. Cells treated with
polyamine biosynthesis inhibitors in the absence of
estradiol retained the binding of their ER with a
45 kDa protein and the ER also showed low-aYnity
interactions with a number of cellular proteins;
however, these associations were decreased by the
presence of estradiol and the inhibitors. When
samples from the estradiol+DFMO treatment
group were incubated with spermidine prior to
GST-ER pull down assay, an increased association
of several proteins with ER was detected. The
intensity of the ER-associated 45 kDa protein
increased by 10-fold in the presence of 1000 µM
spermidine. These results indicate a speciﬁc role for
spermidine in ER association of proteins. Western
blot analysis of samples eluted from GST-ER
showed the presence of chicken ovalbumin up-
stream promoter-transcription factor, an orphan
nuclear receptor, and the endogenous full-length
ER. These results show that multiple proteins
associate with ER and that the binding of some of
these proteins is highly sensitive to intracellular
polyamine concentrations. Overall, our results
indicate the importance of the polyamine pathway
in the gene regulatory function of estradiol in breast
cancer cells.
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INTRODUCTION
Polyamines – putrescine, spermidine and spermine
– are organic cations with multiple functions in cell
proliferation, diVerentiation and apoptosis (Tabor &
Tabor 1984, Heby & Persson 1990, Poulin et al.
1993, McCloskey et al. 1996, Hu & Pegg 1997).
They interact with cellular macromolecules such
as DNA, RNA, proteins and phospholipids and
alter their structure and conformation. In breast
cancer cells, growth stimulatory agents such as
estradiol up-regulate the activity of enzymes
involved in polyamine biosynthesis pathways,
ornithine decarboxylase (ODC) and S-adenosyl
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intracellular polyamine levels (Thomas & Thomas
1993, Thomas et al. 1996). An inhibitor of ODC,
diﬂuoromethylornithine (DFMO), blocks cell pro-
liferation and this eVect can be reversed by
exogenous putrescine or spermidine (Metcalf et al.
1978, Tabor & Tabor 1984, Thomas & Kiang
1987a). An inhibitor of SAMDC, CGP 48664,
also inhibits breast cancer cell growth in a revers-
ible manner (Thomas et al. 1996). Polyamine-
mediated modulation of cell growth and the ability
of ODC to facilitate the action of src (Moshier et al.
1993) and Ki-ras (Tabib & Bachrach 1994)
oncogenes suggest a role for polyamines in
neoplastic cell growth. Recent studies on trans-
genic mice showed that constitutively elevated
ODC expression acts as an endogenous tumor
promoter in carcinogen-initiated epithelial cells
and polyamine depletion by DFMO causes
suppression of tumor growth (Smith et al. 1998).
Signal transduction through the epidermal growth
factor receptor and nuclear receptors is also
reported to be modulated by polyamines (Manni &
Wright 1984, Manni 1989, Faaland et al. 1995,
Thomas et al. 1995), but the mechanism(s) for this
crosstalk is unknown.
Steroid and thyroid hormones, as well as
lipophilic vitamins, act through a family of nuclear
receptors that activate or repress the transcription of
responsive genes after their binding to the appropri-
ate ligands (Beato et al. 1995, Katzenellenbogen
et al. 1996). Ligand binding initiates a cascade of
intracellular events including the dissociation of
heat shock proteins from the nuclear receptors,
association of the receptor with other transcription
factors, and the binding of the receptor to
regulatory sites of the gene to facilitate DNA
conformational changes and the action of RNA
polymerase. Therefore, the action of the ligand is
screened ﬁrst through the strength of the ligand–
receptor interaction, then by protein–protein inter-
actions involving competing transcription factors
and auxiliary proteins, and thirdly by the aYnity
of the ligand–receptor complex for the DNA sites,
the hormone response element. A large number
of receptor-associated proteins that act as co-
regulators (co-activators or co-repressors) of nuclear
receptors are being characterized and their func-
tional interactions with gene regulatory proteins are
an active area of current investigation (Halachmi
et al. 1994, Onate et al. 1995, Horwitz et al. 1996,
Lavinsky et al. 1998). Often the conserved
interaction site of the co-activator is as small as ﬁve
amino acids and appears to ﬁt into a hydrophobic
cleft in the ligand-binding domain of the nuclear
receptor (Feng et al. 1998).
In the present study, we questioned whether
polyamines are involved in gene regulation by
modulating the interaction of estrogen receptor
(ER) and other proteins. We used a glutathione-S-
transferase (GST)-ER fusion protein (consisting of
the ligand binding domain of ER) for this purpose.
In this assay, cellular proteins that bind to the
fusion protein are separated and analyzed by PAGE.
We used cellular extracts from MCF-7 cells treated
with DFMO or CGP 48664 to examine the eVects
of polyamine depletion on ER interaction with other
proteins. Our results indicate that, in the presence
of estradiol, ER association with cellular proteins is
repressed by polyamine depletion in a reversible
manner.
MATERIALS AND METHODS
Materials
CGP 48664 was obtained from Ciba-Geigy Ltd,
Basel, Switzerland. DFMO was from Marrion
Merrell Dow, Cincinnati, OH, USA. GST-ER-
transformed Escherichia coli was obtained from
Dr Myles Brown (Harvard Medical School, Boston,
MA, USA). The GST-ER plasmid consisted of
nucleic acids coding for amino acids 300–596 of ER,
comprising the hormone binding domain as well as
the nonacidic activation domain (AF-2) cloned
downstream to the GST gene (Halachmi et al.
1994). [
35S]methionine was purchased from New
England Nuclear (Boston, MA, USA). Other
reagents were purchased from Sigma Chemical Co.
(St Louis, MO, USA).
Cell culture
MCF-7 cells were obtained from the American
Type Culture Collection (Rockville, MD, USA).
Cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) (Gibco BRL, Long
Island, NY, USA) with 100 µg/ml penicillin,
100 µg/ml streptomycin, 40 µg/ml gentamicin,
2 µg/ml insulin, 0·5 mM sodium pyruvate, 10 mM
nonessential amino acids, 2 mM l-glutamine and
10% fetal bovine serum (Thomas & Kiang 1987a,
Thomas et al. 1996). Prior to each experiment, cells
were grown for 2 weeks in phenol red-free DMEM
containing serum treated with dextran-coated
charcoal (DCC), to remove serum-derived estro-
genic compounds (Thomas & Thomas 1993,
Thomas et al. 1996). Isoleucine-free DMEM was
used for arresting cells in G1 phase. Labeling
with [
35S]methionine was conducted using
methionine-free DMEM.
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Brieﬂy, 5#10
5 cells were seeded in 60 mm
culture dishes in DMEM supplemented with 10%
DCC-treated serum and additives. After 16 h of
plating, cells were treated with 1 mM DFMO or
1 µM CGP 48664 for 24 h. Cells were then
changed to isoleucine-free media for 30 h with
appropriate drugs. Cells were then allowed to
progress in cell cycle in medium containing
isoleucine, 4 nM estradiol and/or the drugs. After
15 h, [
3H]thymidine (2 µCi/ml) was added to the
medium. After 1 h at 37 )C, the cells were washed
with PBS and the radioactive thymidine incorpor-
ated in cellular DNA was quantiﬁed by liquid
scintillation counting (Faaland et al. 1995).
Polyamine assay
Cells (2#10
6) were treated in the same manner
as for the proliferation assay. They were then
harvested and cell pellets treated with 300 µl of 8%
sulfosalicylic acid and sonicated. The solution was
incubated on ice for 1 h and centrifuged at 10 000 g
for 5 min in a microfuge to remove the precipitated
proteins. Intracellular polyamine levels were deter-
mined by an HPLC technique using 1,6-
diaminohexane.2HCl as internal standard (Thomas
& Thomas 1993, Thomas et al. 1996).
GST pull down assay
Cells (3#10
6) were plated in T-75 ﬂasks and
treated with the drugs as described under the
proliferation assay. Ten ﬂasks were used for each
treatment group. We added [
35S]methionine
(0·1 mCi/ml) 12 h after initiation of the cell cycle, in
methionine-free DMEM. Cells were harvested 4 h
after the addition of [
35S]methionine. Cellular lysate
was prepared in 1·5 ml of a buVer containing
50 mM Tris–HCl (pH 7·4), 5 mM EDTA, 150 mM
NaCl, 0·5% NP-40, 1 mM phenyl methylsulfonyl
ﬂuoride, 1 mg/ml leupeptin and 1 mg/ml aprotinin
(Halachmi et al. 1994). E. coli with GST-ER was
seeded in Luria broth medium and allowed to grow
until the absorbance value reached 0·6 at 600 nm.
GST-ER fusion protein was induced by the
addition of isopropyl â-D-thiogalactoside. After 3 h
of growth, bacterial cells were collected and lysed in
ab u Ver containing 0·5% NP-40, 1 mM EDTA,
20 mM Tris pH 8 and 100 mM NaCl (NETN).
After sonication and centrifugation, the supernatant
was incubated with 250 µl aliquots of glutathione–
Sepharose beads. The Sepharose beads were
washed extensively with NETN buVer and then
incubated with 100 µl of cellular extract at 4 )C for
16 h. After three washes with NETN buVer, bound
proteins were eluted with 100 µl of 20 mM
glutathione. Proteins were then analyzed by 12%
denaturing polyacrylamide gels and signals were
ampliﬁed by ﬂuorography.
In order to examine the eVect of exogenous
spermidine on ER association of proteins, aliquots
of cell lysate from the estradiol+DFMO group
were incubated with diVerent concentrations of
spermidine for 90 min at 4 )C. Samples were then
incubated with GST-ER-loaded glutathione–
Sepharose beads and subsequently eluted with
20 mM glutathione.
Western blot analysis
Proteins from GST-ER pull down experiments
were electrophoretically separated on a 10% poly-
acrylamide gel. Pre-stained molecular mass markers
(Sigma Chemical Co., SDS-7B) were loaded in one
of the lanes. The proteins were transferred to
PVDF Immobilon membrane (Millipore, Bedford,
MA, USA). Membranes were incubated in 8% BSA
in Tris-buVered saline (TBS, pH 7·6) containing
0·1% Tween overnight to saturate the nonspeciﬁc
binding sites. The membranes were incubated
either with a 1:1000 dilution of anti-ERá (AER 320,
Lab Vision Corp., Fremont, CA, USA) or with a
1:5000 dilution of polyclonal anti-chicken oval-
bumin upstream promoter-transcription factor
(COUP-TF) antiserum (generously provided by
Janet E Mertz of the University of Wisconsin,
Madison, WI, USA) in 8% BSA–TBS–Tween
buVer for 1 h at room temperature. The membranes
were washed three times with a large volume of
TBS–Tween for a total of 30 min. They were then
incubated with a 1:3000 or 1:10 000 dilution of
secondary antibody in 8% BSA–TBS–Tween
(Klinge et al. 1997). Proteins were visualized with
a chemiluminescence-based detection system. A
series of exposures ranging from 5 to 30 s time
periods was conducted. Identity of protein bands
was conﬁrmed using positive control samples.
Intensities of the signals were quantiﬁed using a
Bio-Rad laser densitometric scanner (Bio-Rad Labs,
Richmond, CA, USA). Protein levels were veriﬁed
by Ponceau dye staining of the blot.
RESULTS
Cell growth inhibitory concentrations of DFMO
and CGP 48664 were chosen from our previous
dose-dependence experiments (Thomas & Kiang
1987a, Thomas & Thomas 1993, Thomas et al.
1996). One millimolar DFMO and 1 µM CGP
48664 were found to be growth inhibitory, but not
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eVects of 4 nM estradiol, 1 mM DFMO or 1 µM
CGP 48664 on DNA synthesis, as determined
by the [
3H]thymidine incorporation assay on the
cells at 16 h after initiation of the cell cycle. This
time point in the cell cycle was chosen because
ﬂow cytometric measurements showed it to repre-
sent transition of G1 cells to the S phase, where
critical estrogenic signals interact with mediators
of cell cycle progression (Thomas & Thomas
1994, Thomas et al. 1997). Estradiol induced a
2-fold increase in DNA synthesis compared with
control cells. DFMO and CGP 48664 inhibited
[
3H]thymidine incorporation in the absence of
estradiol. An estradiol-induced increase in
[
3H]thymidine incorporation was not observed in
cells treated with DFMO. In cells treated with CGP
48664, estradiol caused a 2-fold increase in
[
3H]thymidine incorporation compared with cells
treated with CGP 48664 alone; however, this level
was only 50% of the level in control cells. Thus
polyamine biosynthesis appears to be critical to cell
proliferation in both the presence and absence of
estradiol, although a muted response to estradiol is
produced in cells treated with CGP 48664.
Figure 2 shows the results of our PAGE analysis
of ER-associated proteins in cells during the G1/S
transition of the cell cycle. In control cells, only two
proteins of molecular masses 25 and 45 kDa were
associated with GST-ER, whereas ten proteins
(estimated molecular masses, 300, 180, 160, 140,
100, 60, 45, 30, 28 and 25 kDa) were associated with
GST-ER in cells treated with 4 nM estradiol. The
intensity of the 45 kDa protein was 2-fold higher
than that of control cells. In the absence of estradiol,
DFMO-treated cells showed a low level of ER
association with these proteins, but the 45 kDa
protein was more intense than others. When cells
were treated with DFMO and estradiol, only one
major band corresponding to the 25 kDa protein
was detected. Interestingly, similar results were
obtained in cells treated with CGP 48664. These
results suggest a requirement for polyamines and
estradiol for optimum association of proteins with
ER in the estrogenic pathway of signal transduction.
A set of control experiments was conducted using
the GST expression vector without the region
encoding ER. Analysis of GST-associated proteins
showed the presence of only a 25 kDa protein
(results not shown). Thus the 25 kDa protein of
Fig. 2 appears to be unrelated to ER function.
Table 1 shows a quantiﬁcation of total
proteins, [
35S]methionine-labeled proteins and
figure 1. EVect of DFMO and CGP 48664 on
[
3H]thymidine incorporation in the presence (hatched
bars) or absence (solid bars) of 4 nM estradiol.
G1-synchronized cells progressing in cell cycle for 15 h
were used for the determination of DNA synthesis for
1 h. Data represent means and standard deviations from
two triplicate experiments.
figure 2. EVect of estradiol, DFMO and CGP 48664
on ER-associated proteins in MCF-7 cells. G1-
synchronized cells progressing in cell cycle were labeled
for 4 h with [
35S]methionine. Proteins were detected by
PAGE and ﬂuorography. Positions of molecular mass
markers were indicated from the mobilities of multicolor
markers (Novex, San Diego, CA, USA) and
14C-labeled
proteins (Amersham, Arlington Heights, IL, USA).
Similar results were obtained in three independent
experiments.
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centration was determined by the Bradford protein
assay (Bradford 1976). Radioactivity of the cellular
lysate as well as that of the eluate from GST-
ER–Sepharose beads was used to quantify newly
synthesized and ER-associated proteins respect-
ively. Our results showed that the total protein
level in diVerent treatment groups was not
signiﬁcantly diVerent. [
35S]methionine-labeled pro-
teins in estradiol-treated cells were higher than
those in all other groups, as expected from the
overall mobilization of DNA replication and protein
synthesis machinery by estradiol. Although the
amount of total [
35S]methionine-labeled proteins
was only 2-fold higher in estradiol-treated cells than
in controls, a 5-fold increase in the radioactivity of
ER-associated proteins was found. There was no
signiﬁcant diVerence in [
35S]methionine-labeled
proteins between the DFMO treatment group and
the DFMO+estradiol treatment group. However,
there was a 3-fold decrease in the level of ER-
associated proteins in the presence of DFMO+
estradiol compared with that of the DFMO
treatment group. Results on CGP 48664 treatment
were similar to that of DFMO. These results
suggest that diVerences observed between treatment
groups are mainly due to changes in the ability of
the proteins to associate with ER, rather than
changes in protein synthesis.
Table 2 shows the eVect of DFMO and CGP
48664 on intracellular polyamine levels at 16 h after
initiation of the cell cycle. Estradiol did not
signiﬁcantly increase the level of polyamines
compared with the controls at this time point after
initiation of the cell cycle. Therefore, the estradiol-
induced increase in the level of ER association of
proteins is due to ligand-dependent changes in ER.
DFMO treatment caused a decrease in the level of
putrescine and spermidine, without signiﬁcant
changes in spermine concentration. Treatment of
cells with CGP 48664 reduced spermidine and
spermine levels; however, it increased putrescine
concentrations. Compensatory increases in pu-
trescine after treatment with CGP 48664 have been
previously reported (Regenass et al. 1994, Thomas
et al. 1996). However, this compensatory increase is
table 1. Quantiﬁcation of total, [
25S]methionine-labeled and ER-associated
proteins in MCF-7 cells after treatment with DFMO and CGP 48664. Cells
were treated with DFMO (1 mM) or CGP 48664 (1 µÌ) as described in
Materials and Methods. Cells were metabolically labeled by [
25S]methionine
and harvested 16 h after initiation of the cell cycle. Results are the mean and
standard deviations from three diVerent experiments
Total protein
(mg)
Total c.p.m.
(#10
8)
GST-ER eluate
(c.p.m.10
6)
Treatment
Control 16·2&1·8 3·75&0·23 1·12&0·12
Estradiol 18·0&2·1 5·55&0·42 5·55&0·22
DFMO 20·1&2·3 3·27&0·33 2·99&0·23
DFMO+estradiol 16·3&1·6 2·85&0·24 1·09&0·13
CGP 48664 20·1&1·7 3·30&0·25 3·37&0·25
CGP 48664+estradiol 20·2&2·0 3·45&0·22 1·30&0·10
table 2. EVect of DFMO and CGP 48664 on polyamine levels in MCF-7
cells. Cells were treated with DFMO (1 mM) or CGP 48664 (1 µM) as
described under Materials and Methods. Polyamine levels were determined
using an HPLC technique from cells harvested at 16 h after initiation of the
cell cycle. Restuls are the mean&s.e. from two triplicate experiments
Polyamine concentrations (nmol/mg protein)
Putrescine Spermidine Spermine
Treatment
Control 0·73&0·03 5·50&0·11 5·20&0·38
Estradiol 0·80&0·09 5·18&0·27 6·26&0·15
DFMO 0·28&0·08
a 1·20&0·03
a 4·97&0·29
DFMO+estradiol 0·39&0·06
a 1·16&0·07
a 4·80&0·08
CGP 48664 4·45&0·36
a 2·56&0·14
a 3·27&0·23
a
CGP 48664+estradiol 5·28&0·40
a 2·77&0·06
a 3·38&0·08
a
aSigniﬁcantly diVerent from controls (P<0·05; Student’s t-test).
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Similar changes in ER association of proteins were
induced by both DFMO and CGP 48664 (Fig. 2).
Since reduction of spermidine was the only
common feature in the action of these two
inhibitors, spermidine appears to be a critical factor
in the modulation of ER binding to other proteins.
In order to examine whether the eVect of DFMO
on the level of ER-associated proteins was due to
changes in the pattern of expression of proteins or
due to changes in protein–protein association due
to polyamine depletion, we performed the follow-
ing experiment. Aliquots of cell lysate from the
estradiol+DFMO treatment group were incubated
with 100, 250, 500 and 1000 µM concentrations of
spermidine and then analyzed by the GST-ER pull
down assay. Figure 3 shows our results. Incubation
with 100–1000 µM spermidine caused a dramatic
increase in the association of several proteins
(estimated molecular masses, 300, 180, 160, 140,
100, 80, 60, 45, 35, 30 and 25 kDa). The speciﬁc
protein retained with the highest intensity was a
45 kDa protein. Interestingly, two proteins of
estimated molecular masses 100 and 160 kDa
increased in intensity at 500 µM spermidine, but
decreased at 1000 µM spermidine. In contrast, the
25 kDa protein that appeared to bind to the GST
part of the fusion protein showed no signiﬁcant
change with spermidine concentration and hence it
would serve as an internal control for loading in
each lane. These results show that the reduction of
ER association of proteins with DFMO is mostly
reversible by the addition of spermidine. Secondly,
in the presence of an equal amount of
[
35S]methionine-labeled proteins, reaction mixtures
containing diVerent concentrations of spermidine
yielded diVerent levels of ER-associated proteins,
demonstrating the importance of spermidine in
these protein–protein interactions.
In an attempt to identify ER-associated proteins
observed in Figs 2 and 3, we next examined the
presence of COUP-TF, a transcription factor
known to modulate ER function (Klinge et al. 1997)
as well as the endogenous ER by Western blot
analysis. Figure 4 shows the results of our Western
blot analysis of a sample set identical to that used
in Fig. 3. Anti-COUP-TF and anti-ER anti-
bodies were used as probes in the Western blot.
A high-intensity protein, immunoreactive to
COUP-TF (36 kDa), was identiﬁed in the Western
blot (Fig. 4A). Additional bands showing low
immunoreactivity (78, 58 and 55 kDa) were also
present. Whether these represent nonspeciﬁc bind-
ing or a reactivity of other proteins homologous to
COUP-TF is not known at this time. Interestingly,
the level of COUP-TF binding in the presence and
absence of exogenous spermidine was similar. This
would suggest that COUP-TF binding to ER is
not regulated by spermidine, although it is pulled
down by GST-ER. The high level of immuno-
reactive protein in the absence of corresponding
[
35S]methionine-labeled 36 kDa protein suggests
that COUP-TF is constitutively present in the
G1/S phase cells and that little new synthesis of this
protein is occurring during the 4 h time period of
exposure of these cells to [
35S]methionine.
Western blot analysis using anti-ER antibody
showed only one band of approximately 60 kDa
as expected for full-length ER protein. The level
of endogenous ER associated with the GST-ER
increased by 2-fold at 250 and 1000 µM spermidine,
but the control level was found at 500 µM
figure 3. EVect of spermidine on ER association of
proteins. Cellular lysate samples (100 µl) from
estradiol+DFMO treatment group were incubated with
0, 100, 250, 500 and 1000 µM spermidine at 4 )C for
90 min. The samples were then treated with
GST-ER-loaded glutathione–Sepharose for 16 h and
eluted with 20 mM glutathione. Samples were then
analyzed by SDS PAGE and subjected to
autoradiography.
figure 4. Western blot analysis of the sample set
shown in Fig. 3 using anti-COUP-TF and anti-ER
antibodies. Lanes 1–5 represent 0, 100, 250, 500 and
1000 µM spermidine. The blot was ﬁrst probed with
anti-COUP-TF antibody, then stripped and reprobed
with anti-ER antibody.
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level of protein in lane 4.) Thus, GST-ER
association with endogenous ER is sensitive to the
level of polyamines in the reaction mixture. This
would also suggest that the 60 kDa protein in Figs 2
and 3 is endogenous ER.
DISCUSSION
Our studies show the association of nine cellular
proteins with ER in estradiol-treated MCF-7 cells.
In contrast, only one 45 kDa protein was speciﬁcally
associated with ER in control cells. In cells treated
with DFMO in the absence of estradiol, multiple
proteins were associated with ER at a low level, but
the 45 kDa protein was prominent. In the presence
of DFMO and estradiol, ER association of proteins
decreased, although the nonspeciﬁc association of
the 25 kDa protein was unchanged. The remarkable
up-regulation of ER association of proteins in the
presence of estradiol, the lack of these associations
in the presence of estradiol and DFMO, and the
reversibility of most of the DFMO eVects by
exogenous spermidine indicate a critical role for this
polyamine in ER–protein associations and estrogen-
induced signal transduction pathways in breast
cancer cells. Although COUP-TF and endogenous
ER were identiﬁed as ER-associated proteins, an
uncharacterized 45 kDa protein appears to be a
major regulator of polyamine action in ER function.
Ligand-induced conformational changes in ER may
allow its association with speciﬁc proteins either
as a multi-protein complex or in a sequential
manner. The involvement of polyamine bio-
synthesis in this process indicates a ﬁne tuning of
protein–protein interactions as a requirement for
estrogenic regulation of gene expression and cell
growth. There was an increase in ER association of
proteins in the presence of DFMO alone compared
with controls without estradiol treatment, although
the level of binding is much lower than that
observed in the presence of estradiol. This is in
contrast to a decrease in binding observed in the
estradiol+DFMO group. A plausible explanation
for the association of multiple proteins in the
DFMO group is that polyamines might inhibit
the interaction of unliganded ER with these
proteins, and DFMO increases these interactions
by depleting polyamines. However, in the presence
of estradiol, multiple proteins require polyamines
for optimal association with liganded ER. Thus a
possible mechanism might involve the inhibi-
tion of low-aYnity protein–protein interactions
by polyamines, while facilitating high-aYnity
interactions.
Previous studies have shown that the maximal
increase in polyamine levels after estradiol treat-
ment occurred at 8 h after initiation of the cell cycle
from G1 phase (Thomas & Thomas 1993). The
peak levels of polyamines decreased during the
12–24 h time period. In the absence of estradiol, a
moderate increase in polyamines was observed by
12 h after initiation of the cell cycle (Thomas &
Thomas 1993). Therefore, little diVerence in
polyamines was observed between control and
estradiol-treated samples at the 16 h time point.
Thus the current results are consistent with our
previous observations.
Several recent reports demonstrate the impor-
tance of protein–protein interactions in ER-
mediated signal transduction pathways. Halachmi
et al. (1994) ﬁrst provided evidence for the
association of ER with a novel protein of 160 kDa,
using a GST-ER pull down assay. Later studies by
this group (Hanstein et al. 1996) identiﬁed a
number of proteins from 30 to 300 kDa which
associated with ER. Among these proteins, p300
was characterized as histone acetylase and an
adaptor for several nuclear receptors and cAMP
response factor, thus serving as an integrator of
multiple signal transduction pathways. We found
the presence of a 300 kDa band (Fig. 3) in our
GST-ER pull down assay and its level was
signiﬁcantly increased by exogenous spermidine.
Landel et al. (1994) reported the presence of
ER-associated proteins in ER puriﬁed through
immuno-, steroid- and site-speciﬁc DNA-aYnity
chromatography. Proteins of 70, 55, 48 and 45 kDa
were detected in SDS gels by silver staining. The
70 kDa protein was subsequently identiﬁed as a heat
shock protein (hsp70). N-terminal microsequencing
indicated that the 55 kDa protein was a member of
the protein disulﬁde isomerase family. The 48 and
45 kDa proteins were not identiﬁed. A report by
Cavailles et al. (1994) using a GST-ER pull down
assay identiﬁed 160, 140 and 80 kDa proteins.
Zeiner & Gehring (1995) cloned the cDNA for
ER-associated 45 kDa protein. Other candidates for
the 45 kDa protein include casein kinase II and
cyclin D1, as these proteins have also been reported
to associate with ER.
It is now recognized that the mechanism of
action of nuclear receptors is interlinked by the
presence and interactions of co-activators and/or
co-repressors. For example, the 125 kDa steroid
receptor co-activator-1 protein interacts with
estrogen and progesterone receptors and stimulates
the transcriptional activity of these and other steroid
hormone receptors (Onate et al. 1995). Several
families of co-activators that associate with steroid
receptors and their encoding genes have been
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libraries (Horwitz et al. 1996). It is not as yet
clear how these protein–protein interactions are
integrated by the cell to result in a measured
response in terms of the transcriptional activation.
The ability of a histone acetyltransferase or p300 to
associate with ER and many other sequence-speciﬁc
transcriptional activators appears to serve as a
common integration point (Hanstein et al. 1996,
Ogryzko et al. 1996). Our results suggest that
intracellular polyamine levels might be another
important factor in determining the extent of
protein–protein interactions and transcriptional
responses. Our studies on the interaction of
polyamines with ER by physical chemical methods
indicate that polyamines are able to provoke
structural/conformational changes in ER and alter
its ligand dissociation kinetics (Thomas & Kiang
1987b). More recently, analysis of polyamine-
induced conformational changes in peptides using
circular dichroism spectroscopy indicates that
site-speciﬁc polyamine binding leads to changes in
the á-helical content of the peptide (Tabet et al.
1993). Thus changes in the conformation of ER or
that of other proteins might be important in the
association of proteins with ER and downstream
events regulated by ER.
The mechanism of action of steroid receptors
includes the involvement of protein kinases in
transcriptional activation. Activation of ER
through mitogen-activated protein kinase (Kato et
al. 1995) and the identiﬁcation of ER phosphoryl-
ation at tyrosine 537 and serine 167 (Arnold et al.
1994, 1995) are pertinent. Puriﬁed ER has also
been found to be associated with casein kinase II
(Arnold et al. 1994). Recently, cyclin D1 was
found to be associated with ER (Zwijsen et al.
1997). Thus estrogenic regulation of gene expres-
sion and cell growth appears to involve the
interaction of ER with several kinases, transcrip-
tional co-activators and repressors, as well as cell
cycle regulatory proteins. GST-ER pull down
assays detect possible interactions between ER and
cellular proteins. Reduction of polyamine levels
alters the association of ER with cellular proteins
such that estradiol appears to be unable to activate
gene expression and facilitate cell growth. Changes
in the phosphorylation status of ER or other
proteins may also contribute to the decrease in
protein–protein interactions, since polyamines are
known to increase the activity of casein kinase II
(Cochet & Chambez 1983, Leroy et al. 1997).
However, exogenous addition of spermidine, prior
to GST pull down assays, was able to restore
ER association of proteins, suggesting that the
diVerences in ER-associated proteins observed in
our studies are mostly due to changes in the level
of spermidine.
In summary, our studies indicate that polyamines
are critical to the regulation of ER association of
other proteins. A decrease in cellular polyamine
levels suppressed estradiol-induced increases in the
association of ER with cellular proteins. Addition of
exogenous polyamines increased protein–protein
interactions involving ER. These results support a
functional link between polyamines and estrogenic
function in gene expression and cell proliferation.
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